Eledon Pharmaceuticals, Inc.

Q2 2021 13F Holders

Symbol
ELDN
CUSIP
28617K101
Type
Equity
Class
COM
Num filings
35
Total reported value, excl. options
$74.5 M
Manager Report Date Value ($000) Shares Option Type